
Reshma Jagsi, MD, Dphil, discusses factors that could influence the omission of radiation therapy following breast-conserving surgery in early-stage breast cancer.

Your AI-Trained Oncology Knowledge Connection!


Reshma Jagsi, MD, DPhil is the Lawrence W. Davis Professor and chair of the Department of Radiation Oncology at Emory University School of Medicine.

Reshma Jagsi, MD, Dphil, discusses factors that could influence the omission of radiation therapy following breast-conserving surgery in early-stage breast cancer.

Reshma Jagsi, MD, DPhil, discusses the implications of the IDEA trial for patients with breast cancer.

Reshma Jagsi, MD, Dphil, discusses caveats when interpreting long-term results from the IDEA trial of radiotherapy omission in breast cancer.

Reshma Jagsi, MD, DPhil, discusses 5-year findings from the IDEA trial assessing radiotherapy omission for postmenopausal patients with breast cancer.

As genetic testing becomes increasingly available, there will be a growing gap between the wide availability of testing and the relative importance of results to treatment decisions.

Published: March 1st 2024 | Updated:

Published: November 10th 2015 | Updated: